1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2018-2030)
2.2 Hospital-Acquired Disease Testing Growth Trends by Region
2.2.1 Hospital-Acquired Disease Testing Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Hospital-Acquired Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Region (2023-2030)
2.3 Hospital-Acquired Disease Testing Market Dynamics
2.3.1 Hospital-Acquired Disease Testing Industry Trends
2.3.2 Hospital-Acquired Disease Testing Market Drivers
2.3.3 Hospital-Acquired Disease Testing Market Challenges
2.3.4 Hospital-Acquired Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2018-2023)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2022
3.5 Hospital-Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2023-2030)
5 Hospital-Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2018-2030)
6.2 North America Hospital-Acquired Disease Testing Market Size by Country (2018-2023)
6.3 North America Hospital-Acquired Disease Testing Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2018-2030)
7.2 Europe Hospital-Acquired Disease Testing Market Size by Country (2018-2023)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2018-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size (2018-2030)
9.2 Latin America Hospital-Acquired Disease Testing Market Size by Country (2018-2023)
9.3 Latin America Hospital-Acquired Disease Testing Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2018-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Detail
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Detail
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Detail
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Detail
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Detail
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Detail
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Detail
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2018-2023)
11.9.5 Nordion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
